Lobby groups representing the pharmaceutical and insurance industries are upping their lobbying activities as national pharmacare legislation inches closer to becoming law.
Pro-pharma lobbying picks up as pharmacare bill nears final approval
Groups opposed to a single-payer pharmacare plan stage communications blitz
Share this story